Drug Type CAR-NK |
Synonyms anti-CLL-1 CAR NK cell(Shanghai General Hospital), Anti-human CLL-1 CAR-NK Cell(Shanghai General Hospital) |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 1 | CN | 15 Mar 2024 | |
Refractory acute myeloid leukemia | Phase 1 | CN | 15 Mar 2024 | |
Relapsing acute myeloid leukemia | Phase 1 | CN | 15 Mar 2024 |